8月29日 的 aChiral Clear 應用程式分析
aChiral Clear
- Tech dgit Easy
- Google Play 商店
- 免費版
- 醫療
aChiral Clear is the protected mobile workspace for clinical research and site-monitoring teams. Review study documentation, verify records, and stay on top of oversight tasks from anywhere, with security and traceability built in.
• Review and manage study-critical documents and consent materials, protected on-device and in transit.
• Digitise paper documentation in seconds and file it securely.
• Follow a complete, transparent history of every change.
• Coordinate with your team through built-in secure messaging.
• Sign in with your organisation's SSO, then lock the app behind a personal PIN and biometric unlock.
• Move between sites and studies within a single workspace, online or offline.
Built to the data-integrity expectations of regulated clinical research (ICH-GCP, 21 CFR Part 11, ALCOA+): every action is attributable, logged, and auditable.
WHO IT'S FOR
aChiral Clear is built for the professionals who carry oversight of clinical studies in the field:
• Clinical Research Associates (CRAs) and site monitors
• Study and project managers
• Sponsor and CRO oversight teams
• Data monitoring committees
If that's not your role, this app won't do much for you — and that's by design.
NOT FOR EVERYONE - AND THAT'S THE POINT
aChiral Clear is a professional tool for authorised users of organisations operating within the aChiral ecosystem. It connects to aChiral Carbon and is provisioned per project and role.
If your organisation runs clinical studies and you'd like to see how aChiral fits your monitoring and oversight workflows, get in touch: www.achiral.it - info@achiral.it.
aChiral Clear 使用排名
基於 Similarweb 的算法,根據過去 28 天的安裝數和活躍用戶數進行計算。
所有類別 在
美國--
醫療 在
美國--
每日活躍使用者
通過查看aChiral Clear 的下載量和每日活躍用戶數,分析 aChiral Clear 用戶的使用模式。
位使用者
通過查看aChiral Clear 的下載量和每日活躍用戶數,分析 aChiral Clear 用戶的使用模式。
解鎖每日活躍使用者6月7月8月
隨時間變化的 aChiral Clear 排名統計
Similarweb 的使用排名和Google Play 商店aChiral Clear排名
排名
無可用數據
用戶興趣和熱門類別
aChiral Clear用戶使用的熱門類別和應用程式
無可顯示數據
8月 29, 2026
